APA (7th ed.) Citation

KT, S., MA, S., JB, L., HC, K., PE, C., & K, C. (2016). Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries. International journal of cancer, 139(12), 2771. https://doi.org/10.1002/ijc.30392

Chicago Style (17th ed.) Citation

KT, Simms, Smith MA, Lew JB, Kitchener HC, Castle PE, and Canfell K. "Will Cervical Screening Remain Cost-effective in Women Offered the Next Generation Nonavalent HPV Vaccine? Results for Four Developed Countries." International Journal of Cancer 139, no. 12 (2016): 2771. https://doi.org/10.1002/ijc.30392.

MLA (9th ed.) Citation

KT, Simms, et al. "Will Cervical Screening Remain Cost-effective in Women Offered the Next Generation Nonavalent HPV Vaccine? Results for Four Developed Countries." International Journal of Cancer, vol. 139, no. 12, 2016, p. 2771, https://doi.org/10.1002/ijc.30392.